Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to ...
PARIS (AP) — French drug maker Sanofi, battling development delays with its own vaccine candidates against COVID-19, is turning over more of its vaccine production facilities to industrial competitors ...
Sanofi ( (SNY)) just unveiled an update. In April 2026, Sanofi reported new phase 4 data showing its protein‑based, non‑mRNA COVID‑19 vaccine Nuvaxovid had significantly lower systemic and local ...
LONDON (Reuters) -Sanofi reported stronger than expected third-quarter profit on Friday, boosted by demand for blockbuster asthma drug Dupixent, even as the French drugmaker flagged lower vaccination ...
Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...
LONDON (AP) — Drugmakers Sanofi and GlaxoSmithKline say they will seek regulatory approval for a new COVID-19 vaccine after human trials showed it provided a high level of protection against the ...
PARIS, Feb 4 (Reuters) - Sanofi (SASY.PA), opens new tab is expected to post higher quarterly earnings this week, once more on the back of its star eczema treatment Dupixent as concerns linger about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results